Nevro Corp (NYSE:NVRO)

46.14
Delayed Data
As of May 16
 -1.21 / -2.56%
Today’s Change
41.74
Today|||52-Week Range
182.45
-43.09%
Year-to-Date
Top 5 1st Quarter Trades of Jackson Square Partners, LLC
May 15 / GuruFocus News - Paid Partner Content
Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
May 04 / Zacks.com - Paid Partner Content
Nevro (NVRO) Stock Falls 19% Despite Q1 Earnings Beat
May 09 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close47.35
Today’s open47.13
Day’s range45.36 - 47.50
Volume824,376
Average volume (3 months)626,766
Market cap$1.7B
Data as of 05/16/2022

Growth & Valuation

Earnings growth (last year)-52.94%
Earnings growth (this year)+24.05%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+6.87%
P/E ratio--
Price/Sales7.30
Price/Book5.46

Competitors

 Today’s
change
Today’s
% change
NTUSNatus Medical Inc+0.08+0.25%
CUTRCutera Inc-1.11-2.17%
----
VRAYViewRay Inc-0.16-4.85%
Data as of 05/16/2022

Financials

Next reporting dateAugust 10, 2022
EPS forecast (this quarter)-$0.80
Annual revenue (last year)$386.9M
Annual profit (last year)-$131.4M
Net profit margin-33.95%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Redwood City, California

Forecasts

Chart unavailable